Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
Open | $1.91 |
Close | - |
Volume / Avg. | 36.51K / 42.37K |
Day Range | 1.87 - 2.00 |
52 Wk Range | 1.55 - 5.41 |
Market Cap | $16.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.34% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Other companies in Alterity Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).
There is no analysis for Alterity Therapeutics.
Alterity Therapeutics has a consensus price target of $5.25.
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $1.909 last updated Today at July 18, 2024 at 11:17 AM EDT.
There are no upcoming dividends for Alterity Therapeutics.
Alterity Therapeutics’s Q1 earnings are confirmed for Wednesday, October 2, 2024.
There is no upcoming split for Alterity Therapeutics.
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.